Emergent alpha-beta oscillations are accompanied with worsening motor symptoms in Parkinson’s disease
Objective: The aim of the study was to imply observer-independent approach to search for the ranges of stable oscillations in broad alpha-beta range inside the…Comparing Change in Motor and ADL Rating Scales after DBS in Parkinson’s disease, Dystonia and Tremor
Objective: To assess the relationship between deep brain stimulation (DBS)-induced improvements on motor symptoms and activities of daily living (ADL) in a single-center cohort of…Analysis of excessive daytime sleepiness and clinical findings in Parkinson’s disease
Objective: To explore clinical biomarkers associated with excessive daytime sleepiness (EDS) using a real-world cohort database of Parkinson’s disease (PD). Background: Although evidence for current…Deep brain stimulation modulates subthalamic beta bursts related to movement velocity adjustments in Parkinson’s disease
Objective: The aim of this study was to investigate the role of subthalamic beta bursts for dynamic control of precise drawing movements. Background: The performance…Slow progressive neurocognitive impairment with Parkinsonism: A rare, adult-onset Neuronal Intranuclear Inclusion disease (NIID) case report
Objective: We described a case of a 62-years old lady with underlying diabetes and hypertension, presented with right upper intermittent resting tremor and stiffness for…Unsupervised multimodal digital assessment of fatigue and sleep disorders in Parkinson’s disease: the IDEA-FAST study
Objective: To evaluate fatigue and sleep disorders in unsupervised conditions in neurodegenerative and autoimmune conditions using a combination of mobility, autonomic and sleep digital home…Stepwise Dual-Target MR-guided Focused Ultrasound in A Patient with Advanced Parkinson’s Disease
Objective: To illustrate a successful stepwise dual target MRI guided focused ultrasound ablation in a patient with advanced Parkinson's disease (PD). Background: MR-guided focused ultrasound…Improvement in motor symptoms and quality of life in patients with an earlier stage of advanced Parkinson’s disease treated with foslevodopa/foscarbidopa subcutaneous 24 hour infusion
Objective: To evaluate whether treatment with foslevodopa/foscarbidopa (LDP/CDP), a continuous (24‑hour/day) subcutaneous infusion of carbidopa/levodopa prodrugs, improves motor fluctuations and quality of life (QoL) in…Parkinson’s Disease Hospital Optimization Project
Objective: To describe The Parkinson’s Disease Hospital Optimization Project (PD-HOP) that we established to optimize inpatient care and improve the hospital experience and outcomes for…Clinico-pathological correlations in atypical parkinsonism
Objective: We aim to assess diagnostic accuracy of the Parkinson-plus syndromes (PPS) using the current consensus criteria, whilst identifying the diagnostically most salient clinical features.…
- « Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 186
- Next Page »